Reported Sunday, Specialised Therapeutics To Commercialise, Distribute And Register Incyte's Ruxolitinib Cream (Opzelura) In Australia, Expects To Progress Regulatory And Reimbursement Submissions

Loading news article.

Reported Sunday, Specialised Therapeutics To Commercialise, Distribute And Register Incyte's Ruxolitinib Cream (Opzelura) In Australia, Expects To Progress Regulatory And Reimbursement Submissions | WAPE

Reported Sunday, Specialised Therapeutics To Commercialise, Distribute And Register Incyte's Ruxolitinib Cream (Opzelura) In Australia, Expects To Progress Regulatory And Reimbursement Submissions

Article summary

Related companies

Comments —